Ethnic Vitamin D Studies: Pre-Launch Data Checklist

Large population data do not behave so neatly. In UK Biobank data from more than 440,000 participants, serum values, season, ethnicity, body composition, and exposure patterns intersect in ways that can change the apparent size of a deficiency problem before any intervention begins.

That matters especially for a scientific research project on food fortification with vitamin D. If the baseline model is unstable, the fortification effect can be unstable too. A difference caused by assay platform may look like a difference caused by ancestry. A seasonal trough may be mistaken for a response to the fortified food. A lower serum rise in one subgroup may be attributed to pigmentation when BMI, dietary intake, or supplement use was never measured properly.

This is a pre-launch data checklist in the practical sense: a set of decisions that should be made before recruitment, blood collection, and database lock. The point is not to force every cohort into one explanatory model. It is to make clear which part of the result comes from biology, which part comes from exposure, and which part comes from the way the study was built.

A universal 25(OH)D threshold is a policy choice presented as a biochemical constant. The molecule does not know which society wrote the guideline.

Navigating Diagnostic Variance in Serum 25(OH)D Thresholds

A vitamin D study can use the same analyte, the same participants, and the same laboratory results yet produce different prevalence estimates simply by changing the threshold. The Institute of Medicine marks deficiency at serum 25(OH)D below 20 ng/mL, or 50 nmol/L. The Endocrine Society uses 30 ng/mL, or 75 nmol/L, as its deficiency threshold. The gap is not a rounding issue. It changes who is classified as deficient and therefore changes the headline result.

For a food-fortification trial, this choice affects more than the descriptive baseline table. It can influence eligibility, subgroup balance, the estimated room for improvement, and the interpretation of a post-intervention result. A population that appears to have a modest deficiency burden under one definition may appear to have widespread inadequacy under another.

The severe-deficiency threshold used in the UK Biobank comparison, 25 nmol/L or below, offers a useful cross-study anchor, but it does not resolve the broader disagreement. It identifies a more serious low-status group; it does not tell the reader whether people above that level should be considered sufficient, insufficient, or deficient for the study’s stated endpoint.

The choice should be fixed before the first participant is enrolled. A protocol can designate one threshold as primary and still report sensitivity analyses at other thresholds. What creates avoidable confusion is changing the definition after seeing how many participants fall into each category.

Make the laboratory result transportable

Serum 25(OH)D is not a context-free number. Results can vary with assay method, calibration, laboratory procedures, and the handling of samples collected over a long recruitment period. Differences between liquid chromatography–tandem mass spectrometry and immunoassay methods are especially consequential at low concentrations, precisely where a prevalence estimate is most sensitive to small shifts.

The protocol should therefore specify:

• the assay platform and laboratory responsible for analysis;
• the calibration and quality-control procedure;
• whether samples from different recruitment sites will be tested centrally;
• how samples will be stored, transported, and processed;
• whether the same kit lot or a documented lot-bridging procedure will be used;
• how assay drift will be detected if recruitment lasts multiple years.

A central laboratory does not automatically eliminate bias, but it reduces one source of between-site variation. If more than one platform is unavoidable, the study needs a prespecified harmonization strategy rather than an informal comparison after the results are available.

The unit of measurement also deserves discipline. Reporting ng/mL in one section and nmol/L in another without a clear conversion invites errors in tables, eligibility criteria, and later meta-analysis. Every threshold should appear in both units when the study is intended for an international audience.

Do not let the threshold define the mechanism

A prevalence estimate is not a mechanism. A higher proportion of participants below 30 ng/mL does not, by itself, demonstrate that a subgroup has lower cutaneous synthesis, poorer dietary intake, greater adipose sequestration, or a different response to fortified food. Those explanations require separate measurements.

For that reason, baseline reporting should show the distribution of serum values, not only the percentage below a cutoff. Median values, spread, the proportion at or below 25 nmol/L, and the proportion below both major clinical thresholds allow readers to see whether groups differ across the distribution or only around an arbitrary boundary.

That distinction becomes important when a fortification intervention produces a modest upward shift. If most participants move from just below 75 nmol/L to just above it, the classification change may look dramatic even though the biological shift is limited. Conversely, a meaningful increase among participants with severe deficiency may not move many people across the higher threshold. The statistical endpoint and the biological question must be aligned before the study starts.

Accounting for Skin Pigmentation and UV Synthesis Efficiency

The simplest version of the sunlight model assumes that equal time outdoors produces equal vitamin D synthesis. It does not. Melanin absorbs UVB photons that would otherwise contribute to the conversion of 7-dehydrocholesterol in the skin. Skin pigmentation is therefore relevant to the biological response to exposure, but it is not a substitute for measuring exposure itself.

UK Biobank multivariable data illustrate the problem. Summer outdoor time was associated with weaker protection against vitamin D deficiency among Black African participants, with an odds ratio of 0.89, than among White European participants, for whom the corresponding odds ratio was 0.40. The point is not that one group is biologically uniform or that the odds ratios can be transferred unchanged to every population. The point is that the same behavioral variable does not necessarily represent the same effective UVB exposure or the same serum response across groups.

A study that includes only ancestry or ethnic identity may therefore mislabel a composite phenomenon as an ethnic effect. Pigmentation, clothing, latitude, time outdoors, season, sunscreen use, occupation, and migration history can all sit inside the same observed association.

Measure pigmentation without turning it into ancestry

Ethnic categories are useful for describing social and demographic patterns, but they are poor proxies for skin biology. A protocol concerned with vitamin D synthesis should collect a validated measure of constitutive skin pigmentation where feasible. Fitzpatrick skin phototype I–VI may be practical, although investigators should state how it is assessed and recognize that it is an ordinal clinical classification rather than a direct measurement of melanin concentration.

The distinction between constitutive and facultative pigmentation matters. Recent tanning, sunburn, and other changes in exposed skin can alter a visual assessment without representing the participant’s baseline pigmentation. The protocol should define the assessment site and timing, and should record recent sun exposure if the measure is being used to explain serum values.

Skin pigmentation should not be treated as a single explanatory variable that absorbs everything else. A useful baseline model can include pigmentation alongside:

• self-reported ancestry and ethnicity, clearly defined and collected separately;
• latitude and residential location;
• season and date of blood draw;
• usual outdoor time and time of day;
• clothing coverage and sunscreen use;
• occupation, commuting pattern, and indoor work;
• recent travel to sunnier regions;
• vitamin D supplement and fortified-food intake.

This approach makes the model less rhetorically tidy and more scientifically useful. It also reduces the risk of presenting socially defined categories as if they were biological mechanisms.

Treat sunlight as a dose with context

“Time outdoors” is an incomplete exposure measure. Ten minutes at midday in summer is not equivalent to ten minutes in the late afternoon, and exposure of the face and hands is not equivalent to exposure of larger areas of skin. Latitude changes the available UVB, while cloud cover, season, clothing, and sunscreen alter the dose that reaches the skin.

The study does not need to pretend that a questionnaire can reconstruct every photon. It does need to avoid a single yes-or-no sunlight question. A short, consistent instrument that records frequency, approximate duration, time of day, exposed body area, and seasonal pattern is more informative than a generic question about whether the participant spends time outside.

Latitude belongs in the environmental exposure model, not in a presumed synthesis-rate model. A meta-analysis of oral vitamin D supplementation trials found that latitude was not a significant covariate of the serum 25(OH)D3 response once BMI and dose were accounted for. That finding does not make geography irrelevant. It means that geography should not be used as a shortcut for several different processes that have not been measured.

The ethnic association is often a composite of pigmentation, BMI, diet, season, and behavior. The protocol should separate those ingredients before the discussion section has to do it defensively.

Integrating BMI and Dietary Covariates into Baseline Models

Ethnicity is often placed at the center of the model while BMI, diet, and supplement use are treated as background characteristics. That ordering can make a descriptive comparison look more explanatory than it is. In oral vitamin D supplementation trials, BMI and dose were significant covariates of the serum 25(OH)D3 response, while latitude was not. For a fortification study, this is a direct warning: the amount of vitamin D delivered through the intervention is only one part of the dose that reaches the circulating compartment.

Vitamin D is lipophilic and can be distributed into adipose tissue. Higher body fat can therefore be associated with a smaller serum increase per unit of administered vitamin D, although the relationship is not adequately described by a single universal correction factor. Ethnic cohorts with different BMI distributions may show different average responses to the same fortified food even when their baseline serum concentrations are similar.

BMI should be measured consistently and considered during randomization, stratification, or covariate adjustment. It should not be introduced only after a subgroup difference appears. Depending on the research question and available resources, waist circumference or body-fat percentage may add information that BMI cannot provide. The protocol should specify which measure is primary and how missing or implausible values will be handled.

The analytical role also needs to be stated clearly. Some variables are confounders; others are effect modifiers; some are simply precision covariates. BMI may influence the response to a given dose, which makes interaction testing relevant if the study has adequate power. It may also be associated with dietary pattern, physical activity, and socioeconomic conditions. Calling it merely a “background characteristic” hides these relationships rather than resolving them.

Build the dietary baseline around the intervention

A study of food fortification cannot treat the fortified product as the participant’s only dietary source of vitamin D. Baseline intake should capture naturally occurring sources, fortified foods, supplements, and relevant dietary restrictions. A vitamin-D-specific food-frequency questionnaire may be useful, but its food list must reflect the communities being recruited.

Standard Western questionnaires can miss foods that are common in particular ethnic sub-cohorts. They may also fail to distinguish between a product that is routinely fortified in one country and the same product purchased unfortified in another. The questionnaire should record brand or product type where fortification status varies, as well as the frequency and portion pattern that matter for exposure.

The baseline interview should make room for:

• vitamin D from fortified staple foods, beverages, spreads, and culturally specific products;
• fish, eggs, dairy, and other dietary sources relevant to the population;
• vegetarian, vegan, halal, kosher, and other dietary practices when they affect food selection;
• use of multivitamins or vitamin D preparations;
• recent changes in diet, including food insecurity or changes after migration;
• the frequency with which participants consume the study product or an equivalent product outside the trial.

Vitamin D2 and D3 should not be treated as interchangeable labels. If the intervention contains one form and the background diet contains another, the protocol should specify whether the distinction is biologically or analytically relevant to the endpoint. Some assays do not measure the forms with equal performance. The laboratory method and the intervention formulation therefore need to be considered together.

Supplement use should be recorded as dose, formulation, frequency, and duration, not as a binary yes-or-no variable. “Uses vitamin D” cannot distinguish a daily low-dose preparation from intermittent high-dose use, nor can it show whether the participant stopped supplementation shortly before baseline. For an ethnic cohort vitamin D baseline, that missing detail can create apparent differences that are really differences in prior exposure.

Decide what belongs in the model before seeing the outcome

A pre-launch statistical analysis plan should distinguish:

1. variables used to balance or stratify recruitment;

2. baseline covariates included to improve precision;

3. variables tested as effect modifiers;

4. variables that will be described but not adjusted for because they may lie on the intervention pathway.

This matters in a food-fortification study. If the intervention changes dietary intake, adjusting for post-intervention diet can remove part of the effect the study is intended to estimate. Baseline diet is different: it helps describe starting conditions and may explain variation in response.

The same logic applies to BMI, supplement use, and season. The study should not promise to “control for everything.” It should explain what each variable represents, when it is measured, and why it belongs in the primary model.

Standardizing Seasonal and Geographic Data Collection

Serum 25(OH)D is not a flat baseline across the calendar year. UVB availability, outdoor behavior, clothing, travel, and diet all change over time. If one ethnic subgroup is recruited mostly in winter and another mostly in summer, the study is not making a clean ethnic comparison even if the laboratory process is perfect.

The UK Biobank cross-ethnic figures show the scale of the seasonal effect. The prevalence of deficiency at or below 25 nmol/L fell from 17.5% in winter and spring to 5.9% in summer and autumn among White European participants. Among participants of Asian ancestry, it shifted from 57.2% to 50.8%. Among Black African participants, it shifted from 38.5% to 30.8%. The direction is consistent, but the size of the seasonal change is not. Season interacts with subgroup characteristics rather than simply adding the same amount to every participant.

That interaction is especially important for fortification research. If baseline sampling is unbalanced by season but follow-up is concentrated in a different part of the year, the intervention may appear more effective than it is. A product introduced in late winter and measured in summer benefits from both the intervention and the natural seasonal rise. Without a calendar-aware design, those effects are difficult to disentangle.

Use a calendar that the analysis can actually support

The simplest solution is to match recruitment windows across ethnic sub-cohorts. If matching is impossible, the study should recruit continuously enough to represent the same seasonal cycle in each group and include the date of blood draw in the prespecified model.

Recording only the month is better than recording only the season, but the exact blood-draw date should be retained. Weekly resolution can help identify the spring-to-autumn transition, when UVB exposure and serum values may be changing rapidly. The protocol should also record the date of intervention initiation and follow-up collection, not just the nominal visit number.

Residential geography should be captured at a resolution appropriate to the study. Postcode or an equivalent geographic unit is preferable to a broad self-reported region in a multi-site project. Investigators can then derive latitude, urban or rural context, and distance from the recruitment site without asking participants to estimate geographic variables themselves.

The relevant location is not always the clinic location. Participants may work, study, or spend substantial time elsewhere, and recent travel can produce a short-term exposure that is not reflected in their home address. A brief travel question around baseline and follow-up is often more useful than an elaborate but inconsistent attempt to model every movement.

Consider repeated measures when mechanism is the question

A single time point can estimate status at a particular moment. It cannot reliably distinguish a habitual low concentration from a temporary seasonal trough. If the primary endpoint is prevalence at a defined time, one baseline sample may be appropriate. If the study aims to explain why groups respond differently to fortification, a longitudinal subset is much more informative.

Repeated measures need not be collected from every participant to add value. A planned subset can show within-person seasonal variation and help estimate how much of the between-group difference is temporal. The subset should be selected before recruitment, with attention to representation across ethnic groups, BMI categories, and migration histories.

The timing of follow-up should also match the expected biological response to the fortified food. Measuring too soon may capture partial exposure; measuring after a major seasonal transition may confound response with UVB availability. The protocol should explain why each collection point exists rather than treating visits as interchangeable administrative milestones.

Addressing Disparities in Immigrant and Minority Cohort Data

“Immigrant” and “minority” are not biological strata. They are broad social categories that can conceal substantial variation in origin, migration history, language, diet, skin pigmentation, socioeconomic conditions, and access to fortified foods.

A study of Middle Eastern and African immigrants in Northern Sweden at 63° N reported that 73% of participants had insufficient or deficient serum 25(OH)D3. Severe deficiency below 25 nmol/L was twice as prevalent among African immigrants as among those from the Middle East. The groups shared a host latitude and an immigration context, but they did not share the same serum profile. Pooling them into one immigrant category would erase the contrast that the study needed to examine.

The same problem appears in food-fortification research. A fortified product may be widely consumed by one subgroup and rarely consumed by another because of taste, religious requirements, price, packaging, availability, or distrust of unfamiliar products. A null average effect can therefore represent successful uptake in one group and near-zero exposure in another.

Disaggregate without creating meaningless fragments

The goal is not to split every sample into tiny cells. It is to define meaningful subgroups that correspond to the research question and can be supported by the recruitment plan. Region of origin is usually more informative than the single label “immigrant,” but it should be combined with the variables that explain current exposure.

At minimum, the protocol should consider:

• region or country of origin, collected with a clear coding scheme;
• years since immigration and age at migration;
• generation or place of birth where relevant;
• language preference and need for an interpreter;
• current residence and previous residence in high- or low-UV environments;
• dietary practices and access to fortified foods;
• clothing and outdoor-exposure practices;
• socioeconomic variables that affect food choice and healthcare access.

Years since immigration should be treated as an exposure-related covariate, not as a demographic footnote. Recent arrivals may retain dietary patterns, clothing practices, and sun-exposure habits associated with their country of origin. Long-term residents may adopt the host population’s food environment while maintaining other practices. Neither pattern should be assumed; both should be measured.

Cultural practices also need to be asked about without turning them into stereotypes. Clothing coverage, gender-segregated outdoor time, religious observance, and work patterns may modify UVB exposure, but they vary within every community. A neutral, well-translated question is more useful than an investigator’s assumption about what a group does.

Make dietary recall locally intelligible

An interpreter is not merely a logistical convenience when dietary intake is a primary baseline variable. Participants may know the relevant food by a local name, consume a product with a different fortification standard, or use a preparation method that changes the portion and frequency in ways a standard questionnaire does not capture.

Translation should cover the food list, portion descriptions, response options, and instructions. Cognitive testing with members of the intended communities can identify foods that are missing or questions that appear clear to researchers but not to participants. This is part of measurement validity, not an optional cultural adaptation.

The same care applies to the intervention itself. Labels should make the vitamin D content and serving instructions understandable, but the study should not assume that comprehension guarantees consumption. Distribution records, unused product returns where appropriate, brief adherence measures, and dietary substitution questions can help distinguish biological nonresponse from low exposure to the fortified food.

Plan subgroup analysis around recruitment reality

Small ethnic subgroups are often promised an analysis that the sample cannot support. The problem is not solved by adding more post-hoc comparisons. The protocol should identify the smallest planned subgroup, define the primary contrast, and state which analyses are exploratory.

This is also where missing data can become inequitable. Participants with limited English proficiency, unstable housing, shift work, or lower healthcare access may be more likely to miss blood draws or leave dietary questions incomplete. A complete-case analysis can then make the most difficult-to-reach participants disappear from the result.

Retention plans should be designed with the communities being recruited. Flexible collection times, transport support, translated reminders, trusted community partners, and clear explanations of why blood samples and dietary data are needed can improve both participation and data quality. These measures are not separate from the science: differential loss to follow-up can change the apparent effect of fortification across ethnic groups.

The protocol should make disagreement visible

An ethnic differences vitamin D study protocol is strongest when it makes its points of uncertainty inspectable. The study does not need to claim that one threshold, one pigmentation scale, or one dietary instrument is universally correct. It needs to show how those choices affect the result.

Before launch, investigators should be able to answer, in operational terms:

• Which serum 25(OH)D threshold is primary, and which alternative thresholds will be reported?
• Will all samples be measured on the same platform and under the same quality-control system?
• How will pigmentation be assessed, and how will it be distinguished from self-identified ethnicity?
• Which variables describe UV exposure rather than merely geography?
• How will BMI, body composition, baseline diet, and supplement use enter the model?
• Are recruitment and follow-up balanced across seasons?
• How will the study represent recent migrants, long-term residents, and participants with different dietary traditions?
• What will happen if a subgroup is smaller than planned or has more missing data than expected?
• How will intervention uptake be separated from biological response?

These are not duplicate versions of a generic checklist. Each question protects a different inferential link between exposure and serum outcome. If one link is weak, the result may still be publishable as descriptive evidence, but it should not be presented as a clean explanation of ethnic differences in vitamin D status or fortification response.

The pre-launch stage is where a multicultural vitamin D study design either acquires a defensible comparison or quietly builds in an artifact. Thresholds must be chosen and mapped. Skin pigmentation must be measured without using ancestry as a proxy. BMI and dietary exposure must be visible in the baseline model. Calendar and geography must be recorded at a resolution that can support the intended analysis. Immigrant and minority cohorts must be disaggregated enough to preserve meaningful differences without creating unsupported statistical fragments.

The supplement industry’s simplest story—a daily tablet, a universal serum target, and one average response—does not survive contact with these data. Food fortification research has the same obligation as any other population-health study: define the outcome precisely, measure the exposure people actually receive, and show which parts of the result belong to biology and which belong to the design. Get that architecture right before recruitment, and the dataset has a chance to answer the question it was built to answer.